Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Stomatitis 4Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Pancreatic Neoplasms 1Oral Ulcer 1Esophagitis 1Disease Progression 1Carcinoma, Squamous Cell 1

Interventions

avasopasem manganese 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiation 1Induction Chemotherapy 1Immunonutrition Diet 1Heart Rate 1Glutamine 1Gastropexy 1Fundoplication 1Esomeprazole 1Endoscopy, Digestive System 1Drug Therapy 1Dietary Supplements 1Biopsy 1Amifostine 1Alginates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophagitis × avasopasem manganese × Clear all
NCT04225026 2023-03-23

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

Galera Therapeutics, Inc.

Phase 2 Terminated
39 enrolled 12 charts

Esophagitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡